Editorial: Tumor microenvironment complexity and its therapeutic implications by Denner Santos dos Anjos, Marxa Leão Figueiredo, Renee Laufer-Amorim, Carlos Eduardo Fonseca-Alves, Carlos Eduardo Fonseca-Alves, Carlos Eduardo Fonseca-Alves

Subjects: Get full text

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023 by Siqi Zhang, Lina Miao, Xiaoxia Tian, Bingxu Yang, Baoping Luo

Subjects: “…Immuno-oncology…”
Get full text

RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties by Barnabas Nyesiga, Mattias Levin, Anna Säll, Anna Rosén, Kim Jansson, Sara Fritzell, Karin Hägerbrand, Dietmar Weilguny, Laura von Schantz

Subjects: Get full text

Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53 by Iulianna C. Taritsa, Eric T. Fossel

Subjects: Get full text

A patient-derived HCC spheroid system to model the tumor microenvironment and treatment response by Emilie Crouchet, Nuno Almeida, Sarah C. Durand, Marie Parnot, Marine A. Oudot, Fabio Giannone, Cloé Gadenne, Natascha Roehlen, Antonio Saviano, Emanuele Felli, Patrick Pessaux, Hong Tuan Duong, Hideki Ohdan, Hiroshi Aikata, Kazuaki Chayama, Thomas F. Baumert, Catherine Schuster

Subjects: Get full text